35115992|t|Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies.
35115992|a|Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) lie at opposing ends of a clinical, genetic, and neuropathological continuum. In the last decade, it has become clear that cognitive and behavioral changes in patients with ALS are more frequent than previously recognized. Significantly, these non-motor features can impact the diagnosis, prognosis, and management of ALS. Partially overlapping neuropathological staging systems have been proposed to describe the distribution of TAR DNA-binding protein 43 (TDP-43) aggregates outside the corticospinal tract. However, the relationship between TDP-43 inclusions and neurodegeneration is not absolute and other pathophysiological processes, such as neuroinflammation (with a prominent role of microglia), cortical hyperexcitability, and synaptic dysfunction also play a central role in ALS pathophysiology. In the last decade, imaging and biofluid biomarker studies have revealed important insights into the pathophysiological underpinnings of extra-motor neurodegeneration in the ALS-FTLD continuum. In this review, we first summarize the clinical and pathophysiological correlates of extra-motor neurodegeneration in ALS. Next, we discuss the diagnostic and prognostic value of biomarkers in ALS and their potential to characterize extra-motor neurodegeneration. Finally, we debate about how biomarkers could improve the diagnosis and classification of ALS. Emerging imaging biomarkers of extra-motor neurodegeneration that enable the monitoring of disease progression are particularly promising. In addition, a growing arsenal of biofluid biomarkers linked to neurodegeneration and neuroinflammation are improving the diagnostic accuracy and identification of patients with a faster progression rate. The development and validation of biomarkers that detect the pathological aggregates of TDP-43 in vivo are notably expected to further elucidate the pathophysiological underpinnings of extra-motor neurodegeneration in ALS. Novel biomarkers tracking the different aspects of ALS pathophysiology are paving the way to precision medicine approaches in the ALS-FTLD continuum. These are essential steps to improve the diagnosis and staging of ALS and the design of clinical trials testing novel disease-modifying treatments.
35115992	36	65	Extra-Motor Neurodegeneration	Disease	MESH:D000092225
35115992	69	98	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
35115992	137	166	Amyotrophic lateral sclerosis	Disease	MESH:D000690
35115992	168	171	ALS	Disease	MESH:D000690
35115992	177	210	frontotemporal lobar degeneration	Disease	MESH:D057174
35115992	212	216	FTLD	Disease	MESH:D057174
35115992	377	385	patients	Species	9606
35115992	391	394	ALS	Disease	MESH:D000690
35115992	536	539	ALS	Disease	MESH:D000690
35115992	648	674	TAR DNA-binding protein 43	Gene	23435
35115992	676	682	TDP-43	Gene	23435
35115992	762	768	TDP-43	Gene	23435
35115992	784	801	neurodegeneration	Disease	MESH:D019636
35115992	866	883	neuroinflammation	Disease	MESH:D000090862
35115992	1003	1006	ALS	Disease	MESH:D000690
35115992	1161	1190	extra-motor neurodegeneration	Disease	MESH:D000092225
35115992	1198	1201	ALS	Disease	MESH:D000690
35115992	1202	1206	FTLD	Disease	MESH:D057174
35115992	1303	1332	extra-motor neurodegeneration	Disease	MESH:D000092225
35115992	1336	1339	ALS	Disease	MESH:D000690
35115992	1411	1414	ALS	Disease	MESH:D000690
35115992	1451	1480	extra-motor neurodegeneration	Disease	MESH:D000092225
35115992	1572	1575	ALS	Disease	MESH:D000690
35115992	1608	1637	extra-motor neurodegeneration	Disease	MESH:D000092225
35115992	1780	1797	neurodegeneration	Disease	MESH:D019636
35115992	1802	1819	neuroinflammation	Disease	MESH:D000090862
35115992	1880	1888	patients	Species	9606
35115992	2009	2015	TDP-43	Gene	23435
35115992	2106	2135	extra-motor neurodegeneration	Disease	MESH:D000092225
35115992	2139	2142	ALS	Disease	MESH:D000690
35115992	2195	2198	ALS	Disease	MESH:D000690
35115992	2274	2277	ALS	Disease	MESH:D000690
35115992	2278	2282	FTLD	Disease	MESH:D057174
35115992	2360	2363	ALS	Disease	MESH:D000690
35115992	Association	MESH:D000690	23435
35115992	Association	MESH:D019636	23435
35115992	Association	MESH:D000092225	23435

